Isotype choice for chimeric antibodies affects binding properties.
Maurice M. Morelock(Boehringer Ingelheim (Brazil)), David S. Scher(Boehringer Ingelheim (Brazil)), Robert Rothlein(Thomas Jefferson University), Michael K. Robinson(Boehringer Ingelheim (Brazil)), Edward T. Graham(Boehringer Ingelheim (Brazil)), Stephen H. Norris(Boehringer Ingelheim (Brazil)), John P. Sabo(Boehringer Ingelheim (Brazil)), Raymond J. Owens(Rosalind Franklin Institute), David J. King(Regulus Therapeutics (United States)), Susan Bright(Boehringer Ingelheim (Brazil))
Cited by 51
Related Papers
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications
|Nucleic Acids Research|2007|571
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion.
|Circulation|1992|293
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
|Molecular Immunology|1993|243